Literature DB >> 5936856

Reversible retroperitoneal fibrosis with ureteral obstruction associated with ingestion of sansert.

J M Weiss, F Hinman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1966        PMID： 5936856     DOI： 10.1016/s0022-5347(17)63538-9

Source DB:  PubMed          Journal:  J Urol        ISSN： 0022-5347            Impact factor:   7.450


× No keyword cloud information.
  4 in total

1.  Drug-induced retroperitoneal fibrosis: short aetiopathogenetic note, from the past times of ergot-derivatives large use to currently applied bio-pharmacology.

Authors:  C Alberti
Journal:  G Chir       Date:  2015 Jul-Aug

2.  Retroperitoneal fibrosis secondary to methysergide bimaleate.

Authors:  N C Kerbel
Journal:  Can Med Assoc J       Date:  1967-05-27       Impact factor: 8.262

3.  Retroperitoneal fibrosis.

Authors:  J C Ross
Journal:  Proc R Soc Med       Date:  1968-02

4.  Retroperitoneal fibrosis after long-term daily use of ergotamine.

Authors:  L Damstrup; T T Jensen
Journal:  Int Urol Nephrol       Date:  1986       Impact factor: 2.370
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.